Newsroom

MD Anderson ranked No. 1 in the nation for cancer care

July 15, 2024

The University of Texas MD Anderson Cancer Center today was ranked number one in the nation for cancer care in U.S. News & World Report’s 2024-25 "Best Hospitals" survey. Since the survey's inception in 1990, MD Anderson has consistently been one of the top two hospitals in the nation for cancer care, and it has maintained the top ranking for the past 10 years.

“At MD Anderson, our mission is clear: to end cancer,...

ASCO: HER2-targeted antibody drug conjugate shows strong anti-tumor activity and durable responses across multiple tumor types

BY Glenecia Green

June 05, 2023

ABSTRACT: LBA3000

In a new study of trastuzumab deruxtecan, a HER2-targeted antibody drug conjugate, researchers observed encouraging...

ARCHIVED: ‘Reversible’ tumor suppressor loss: key to new brain cancer therapies?

BY Glenecia Green

October 19, 2015

MD Anderson study shows why protein PTEN causes tumor growth in brain but not in other organs

MD Anderson News Release 10/19/15

ARCHIVED: Novel regulatory mechanism for cell division found

November 21, 2014

MD Anderson study zeroes in on enzyme PKM2

MD Anderson News Release 11/21/2014

A protein kinase or enzyme known as PKM2 has proven to control cell division, potentially providing a molecular basis for tumor diagnosis and treatment.

A study, led by Zhimin Lu, M.D., Ph.D., professor of neuro-oncology at The University of Texas
MD Anderson Cancer Center, showcased the non-metabolic abilities of PKM2 (pyruvate...